MTOR and familial pancreatic carcinoma: The mammalian target of rapamycin (mTOR)-p65 axis showed sustained activation and was responsible for radiotherapy-induced CXCL8 release, which caused directional migration of NK cells to the TME in patients with pancreatic cancer (82).